Hinge Health (HNGE) director takes 246-share RSU compensation grant, holds 10,210

Rhea-AI Filing Summary

Hinge Health, Inc. director Tyler Sloat acquired 246 shares of Class A Common Stock through the settlement of fully vested restricted stock units on July 5, 2026. These RSUs were granted in lieu of quarterly cash retainers under the company’s Non-Employee Director Compensation Program.

Following this equity grant, Sloat directly holds 10,210 shares of Class A Common Stock. This is a routine, compensation-related award rather than an open-market stock purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sloat Tyler

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	246	$65.847	$16K

Holdings After Transaction: Class A Common Stock — 10,210 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU shares settled: 246 shares Transaction price per share: $65.847 per share Shares held after transaction: 10,210 shares

3 metrics

RSU shares settled 246 shares Class A Common Stock issued on July 5, 2026

Transaction price per share $65.847 per share Price reported for RSU settlement

Shares held after transaction 10,210 shares Direct Class A Common Stock holdings after RSU issuance

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, Class A Common Stock

3 terms

restricted stock units ("RSUs") financial

"Represents shares of Class A Common Stock issued upon settlement of fully vested restricted stock units ("RSUs") awarded to the Reporting Person"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"pursuant to the Issuer's Non-Employee Director Compensation Program"

Class A Common Stock financial

"Represents shares of Class A Common Stock issued upon settlement of fully vested restricted stock units"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 07:47 PM Accepted by SEC EDGAR 07/07/2026 - 07:46 PM Learn about SEC filing dates

FAQ

What insider transaction did Hinge Health (HNGE) report for Tyler Sloat?

Hinge Health reported that director Tyler Sloat received 246 shares of Class A Common Stock via settlement of fully vested RSUs. The RSUs were part of his director compensation and were issued instead of a quarterly cash retainer.

Was Tyler Sloat’s HNGE transaction an open-market stock purchase or sale?

No. The 246 Hinge Health shares were issued through settlement of fully vested RSUs, not bought or sold on the open market. The award represents non-cash director compensation under the company’s Non-Employee Director Compensation Program.

How many Hinge Health (HNGE) shares does Tyler Sloat hold after this Form 4?

After this RSU settlement, Tyler Sloat directly holds 10,210 shares of Hinge Health Class A Common Stock. This figure reflects his position immediately following the 246-share compensation-related issuance reported in the Form 4 filing.

Why did Hinge Health (HNGE) grant RSUs to Tyler Sloat instead of cash?

The filing states the RSUs were granted in lieu of quarterly cash retainers, at Sloat’s election. This aligns with Hinge Health’s Non-Employee Director Compensation Program, which allows directors to receive equity awards instead of cash compensation.

What was the reported price per share for Tyler Sloat’s HNGE RSU settlement?

The RSU settlement for Tyler Sloat used a reported price of $65.847 per share for the 246 Hinge Health Class A Common shares. This figure appears in the Form 4 as the transaction price per share for the stock issued.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sloat Tyler

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/05/2026		A		246(1)	A	$65.847	10,210	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Class A Common Stock issued upon settlement of fully vested restricted stock units ("RSUs") awarded to the Reporting Person on July 5, 2026. The RSUs were granted to the Reporting Person in lieu of quarterly cash retainers, at the election of the Reporting Person, pursuant to the Issuer's Non-Employee Director Compensation Program.

	/s/ James Budge, Attorney-in-Fact	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)